Company attributes
Industry
Location
Pitchbook URL
Founded Date
2007
Venture Capital Firm attributes
Invested in
Other attributes
Company Operating Status
Closed
Mulligan BioCapital is an investment firm in Germany that is dedicated to the life sciences with a specific focus on biotechnology with health care applications. Founded 2007 in Hamburg, Germany, this microventure capital firm invests in late stage ventures. Its portfolio companies include DIREVO Industrial Biotechnology, Spinal Cord Therapeutics GmbH, 4-Antibody AG, 4SC, and Cardion. As of February 2020, Mulligan BioCapital has made six investments. Their most recent investment was on Oct 18, 2007, when DIREVO Industrial Biotechnology raised $16.8M. Mulligan BioCapital has had three exits. Its most notable exits include 4SC, DIREVO Industrial Biotechnology, and 4-Antibody AG.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Associated Investment Funds
Accelerator Batches
Patents
Funding Rounds Participated In
Further Resources
No Further Resources data yet.
